Parent Terms |
Term With Siblings |
Child Terms |
|
(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl]-1-[(3R,6S,9R,12R,15S)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-butan-2-yl-15-[(4-methoxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]pyrrolidine-2-carboxamide
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide
(3S,6S,9S,12R)-3-[(2R)-butan-2-yl]-6-[(1-methoxy-3-indolyl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
(3S,6S,9S,12R)-3-butan-2-yl-6-[(1-methoxy-3-indolyl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
(3S,6S,9S,12S)-3,9-bis(3-aminopropyl)-6-[(4-hydroxyphenyl)methyl]-12-methyl-1,4,7,10-tetrazacyclododecane-2,5,8,11-tetrone
(cyclo(L-Val-D-Ile-L-Leu-L-pro-D-Leu))
(cyclo(N-methyl-L-Phe-L-Val-D-Ile-L-Leu-L-Pro))
2-(\{[3-ethyl-6,9,11,15-tetrahydroxy-3-methyl-10-(methylamino)-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(15),5,8,12(16),13-pentaen-4-yl](hydroxy)methylidene\}amino)acetic acid
2-[(2R,5S,8S,11S)-11-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid
2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid bis[1-[10,13-dimethyl-2,5,8,11,14-pentaoxo-3,9-di(propan-2-yl)-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]ethyl] ester
3-(1h-indol-3-ylmethyl)-6,18-dimethyl-12-(1-phenylethyl)-9,15-di(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclotricosane-2,5,8,11,14,17,20-heptone
6,9-dimethyl-3-[6-(2-oxiranyl)-6-oxohexyl]-1,4,7,10-tetrazabicyclo[10.3.0]pentadecane-2,5,8,11-tetrone
6-benzyl-3-butan-2-yl-9-(7,8-dihydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
8-amino-[1,4]diazonane-2,5-dione
BQ 123 A cyclic peptide that has formula C31H42N6O7.
Cyclo(glycylleucylvalylleucylprolylseryl)
Cyclo(L-alpha-Glutamyl-L-prolyl-L-alpha-
Cyclo(L-Tyr-L-Pro-L-Phe-trans-4-hydroxy-L-Pro)
Cyclo-(glycyl-L-prolyl-L-glutamyl)
Cyclo-(glycyl-L-seryl-L-prolyl-L-glutamyl)
Cyclo-(L-Ile-L-Glu-L-Ile-L-Glu)
Cyclo-(L-Leu-L-Glu-L-Leu-L-Glu)
Cyclo-(L-Pro-L-Tyr-L-Pro-Val-)
Cyclo-(L-Val-L-Glu-L-Val-L-Glu)
Cyclo-[L-Tyr-L-Leu-D-Pro]
Cyclo-[phenylalanyl-prolyl-leucyl-prolyl]
heterodetic cyclic peptide +
homodetic cyclic peptide +
Ile+CO[Lys+Val+Hph+MeHty+AcSer]
Ile+CO[Lys+Val+Hph+MeHty+MetO]
Phe+CO[Lys+Val+Hty+MeGly+Phe]
Phe+CO[Lys+Val+Leu+MeHty+MetO]
Piricyclamide ILGEGEGWNYNP
Piricyclamide TLGCM(O)NGTERCLGLP
Piricyclamide TLGCMNGTERCLGLP
|
|
|
Synonyms |
Related Synonyms: |
Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]
;
Formula=C31H42N6O7
;
InChI=1S/C31H42N6O7/c1-16(2)12-21-27(40)33-22(13-18-15-32-20-9-6-5-8-19(18)20)28(41)35-23(14-25(38)39)31(44)37-11-7-10-24(37)29(42)36-26(17(3)4)30(43)34-21/h5-6,8-9,15-17,21-24,26,32H,7,10-14H2,1-4H3,(H,33,40)(H,34,43)(H,35,41)(H,36,42)(H,38,39)/t21-,22+,23+,24-,26+/m0/s1
;
InChIKey=VYCMAAOURFJIHD-PJNXIOHISA-N
;
SMILES=CC(C)C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O)C(C)C
|
Xrefs: |
CAS:136553-81-6
;
KEGG:C11587
|
Xref Mesh: |
MESH:C072247
|
|